Oncology Institute, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oncology Institute, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q4 2024.
  • Oncology Institute, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $25.8M, a 11.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $25.8M -$3.39M -11.6% Dec 31, 2024 10-K 2025-03-26
Q3 2024 $27.1M -$1.45M -5.08% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $27M -$2.05M -7.06% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $27.4M +$2.74M +11.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $29.2M +$4.68M +19.1% Dec 31, 2023 10-K 2025-03-26
Q3 2023 $28.5M +$3.73M +15% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $29M +$11.8M +68.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $24.7M +$7.45M +43.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $24.5M +$24.5M Dec 31, 2022 10-K 2024-03-28
Q3 2022 $24.8M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $17.3M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $17.2M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.